The urokinase receptor/uPAR is a major effector of p53 gain-of-function mutations in gemcitabine-treated pancreatic ductal adenocarcinoma
C
Carlotta Zampieri
K
Kourosh Kouhmareh
P
Parnian Sartipdolagh
P
Pardis Azmoon
R
Richard L. Klemke
S
Steven L. Gonias
Article Details
Journal
Journal of Biological Chemistry
Volume / Issue
Vol. 301, Issue 9
Published
September 01, 2025
Pages
110561
ISSN
0021-9258
Publisher
Elsevier BV
Authors (6)
C
Carlotta Zampieri
K
Kourosh Kouhmareh
P
Parnian Sartipdolagh
P
Pardis Azmoon
R
Richard L. Klemke
S
Steven L. Gonias
Related Articles from this Journal
Asialoglycoprotein receptor subunit Asgr1a loss results in attenuated cholesterol absorption in zebrafish fed a western diet
Joshua T. Derrick, Tabea O.C. Moll et al.
Aug 2026
10.1016/j.jbc.2026.113239
Nrf2-mediated epigenetic priming of osmoprotective genes enhances cellular adaptation to hyperosmotic stress
Yi Lu, Na Li et al.
Aug 2026
10.1016/j.jbc.2026.113278
Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function
Kailash Venkatraman, Daniel Milshteyn et al.
Aug 2026
10.1016/j.jbc.2026.113306
Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression
Katerina-Marina Pilala, Artemis-Melina Papadimitriou et al.
Aug 2026
10.1016/j.jbc.2026.113302
Correction: Abstract 5588 Multifunctional carbon dots nanocarriers: Dual-drug delivery via π-π stacking interaction for stimuli-responsive chemotherapy and high oxidative stress
Girum Demissie, Jia Chang
Aug 2026
10.1016/j.jbc.2026.113253